Selective mutism: a review of the concept and treatment.
Berger
Itai
I
Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem, Israel. itberg@szmc.org.il
Jaworowski
Solomon
S
Gross-Tsur
Varda
V
D001007:Anxiety / Q000150:complications; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009155:Mutism / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D010624:Phenelzine / Q000627:therapeutic use*; D010698:Phobic Disorders / Q000150:complications; D015995:Prevalence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D005473:Fluoxetine; D008996:Monoamine Oxidase Inhibitors; D010624:Phenelzine; D017367:Selective Serotonin Reuptake Inhibitors